neurological function News
-
Nevro Responds to Competitor`s Announcement of FDA Approval for Painful Diabetic Neuropathy
REDWOOD CITY, Calif., Jan. 25, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today responded to Medtronic's announcement of FDA approval for painful diabetic neuropathy (PDN). "PDN represents a very large potential market, and having another competitor validate this large ...
By Nevro Corp.
-
Daxor’s Blood Volume Analyzer (BVA-100) to Be Used As a Key Metric in Study of “Long Hauler” COVID-19 Patients
Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today participation in the National Institutes of Health (NIH) Intramural Research Program-sponsored study titled “An Observational Study of Neurologic Function after COVID-19 Infection” utilizing Daxor’s BVA-100 (Blood Volume Analyzer, “BVA”) technology. The study is ...
-
STALICLA completes successful phase 1b trials for the first precision medicine in autism spectrum disorder
Clinical data clear major test for the first precision neurodevelopmental disorders discovery platform, with a first application in Autism Spectrum Disorder (ASD) STALICLA, a Swiss clinical stage biotech company leading omics-based drug development for patients with neurodevelopmental disorders (NDDs), announced today the highly successful completion of the phase 1b trials for its lead ...
By STALICLA
-
FDA Awards Breakthrough Device Designation to the ReWalk ReBoot Soft Exo-Suit
ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading global manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced its ReBoot device has been granted designation as a Breakthrough Device by the Food and Drug Administration (FDA). The ReBoot is a lightweight, battery-powered orthotic exo-suit intended to assist ambulatory ...
-
MCS America Launches Vaccine/Mercury/Autism Webpage
Salem, NY - The Autism Society of America (2007) defines autism as a complex developmental disability that typically appears during the first three years of life and is the result of a neurological disorder that affects the normal functioning of the brain, impacting development in the areas of social interaction and communication skills. Both children and adults with autism typically show ...
By MCS America
-
GE Researches dedicated MRI Brain Scanner Technology
Driving new technologies that will help expand the availability of MRI scanners beyond the hospital to smaller clinic settings, GE Global Research, the technology development arm for the General Electric Company (NYSE: GE), and Mayo Clinic, have received a five-year, $5.7 million grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), and the National Institute of ...
By GE Power
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you